CO69 Indirect Treatment Comparison of Iptacopan Versus Eculizumab and Ravulizumab for Patients With Paroxysmal Nocturnal Hemoglobinuria Naive to C5 Inhibitors
Abstract
Authors
Peffault de Latour R P Scheinberg P Spin MM Balp K Pannagl A Wiyani O Somenzi J Snellman P Wang J Steenkamp A Kulasekararaj